Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by ...

For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...

The diabetes drug, Ozempic, has been in the headlines, causing quite a stir. Senior writer for Drugwatch.com, Terry Turner, ...

But their weight-loss properties grabbed the attention of the public and people without diabetes started seeking these drugs.